☆ 4.5 Editorial Material

Fatty liver disease and primary liver cancer: disease mechanisms, emerging therapies and the role of bariatric surgery

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2020)

Get Full Text
Add to Collection

Journal

EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 29, Issue 2, Pages 107-110

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/13543784.2020.1721457

Keywords

NASH; obesity; metabolic syndrome; primary liver cancer; lifestyle intervention; hepatocellular carcinoma; nonalcoholic steatohepatitis; bariatric surgery; nafld; obeticholic acid

Categories

Pharmacology & Pharmacy

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.